Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018–2020)
Hélio S. Sader, Rodrigo E. Mendes, Jennifer M Streit, et al.
Diagnostic Microbiology and Infectious Disease (2021) Vol. 102, Iss. 1, pp. 115557-115557
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Global Prevalence of Colistin Resistance in Klebsiella pneumoniae from Bloodstream Infection: A Systematic Review and Meta-Analysis
Leonard Ighodalo Uzairue, Ali A. Rabaan, Fumilayo Ajoke Adewumi, et al.
Pathogens (2022) Vol. 11, Iss. 10, pp. 1092-1092
Open Access | Times Cited: 42
Antimicrobial stewardship in the intensive care unit
Zeynep Türe, Rahmet Güner, Emine Alp
Journal of Intensive Medicine (2022) Vol. 3, Iss. 3, pp. 244-253
Open Access | Times Cited: 24
Donor respiratory multidrug-resistant bacteria and lung transplantation outcomes
Rayid Abdulqawi, Rana Saleh, Reem Alameer, et al.
Journal of Infection (2024) Vol. 88, Iss. 2, pp. 139-148
Open Access | Times Cited: 4
Difficult-to-Treat Pseudomonas aeruginosa Infections in Critically Ill Patients: A Comprehensive Review and Treatment Proposal
Pablo Vidal, Sandra Campos-Fernández, Elena Cuenca-Fito, et al.
Antibiotics (2025) Vol. 14, Iss. 2, pp. 178-178
Open Access
What to Do with the New Antibiotics?
Khalil Chaïbi, Françoise Jauréguy, Hermann Do Rego, et al.
Antibiotics (2023) Vol. 12, Iss. 4, pp. 654-654
Open Access | Times Cited: 11
Treatment of Severe Infections Due to Metallo-Betalactamases Enterobacterales in Critically Ill Patients
Jean‐François Timsit, Paul-Henri Wicky, Étienne de Montmollin
Antibiotics (2022) Vol. 11, Iss. 2, pp. 144-144
Open Access | Times Cited: 14
Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development
Qiuxia Liao, Feng Zhi, Hairong Lin, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis
Masoumeh Beig, Elnaz Parvizi, Tahereh Navidifar, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0311124-e0311124
Open Access | Times Cited: 2
Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Acinetobacter baumannii infections in critically ill children
Yufei Zhang, Guifeng Xu, Fei Miao, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 6
Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex
Kay A. Ramsay, Attika Rehman, Samuel T. Wardell, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0285856-e0285856
Open Access | Times Cited: 5
Activity of ceftolozane/tazobactam, imipenem/relebactam and ceftazidime/avibactam against clinical Gram-negative isolates—SMART United States 2019–21
James A. Karlowsky, Sibylle Lob, Karri A. Bauer, et al.
JAC-Antimicrobial Resistance (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 5
An analysis of differences in Carbapenem-resistant Enterobacterales in different regions: a multicenter cross-sectional study
Bo Guo, Peili Li, Bingyu Qin, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Epidemiology of extended-spectrum β-lactamases in Enterobacterales in Taiwan for over two decades
Chien‐Ming Chao, Chih-Cheng Lai, Wen‐Liang Yu
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 4
Source Control of Gram-Negative Bacteria Using Self-Disinfecting Sinks in a Swedish Burn Centre
Maria Gideskog, Tina Falkeborn, Jenny Welander, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 965-965
Open Access | Times Cited: 4
Minocycline and the SPR741 Adjuvant Are an Efficacious Antibacterial Combination for Acinetobacter baumannii Infections
Yonas A. Alamneh, Vlado Antonic, Brittany Garry, et al.
Antibiotics (2022) Vol. 11, Iss. 9, pp. 1251-1251
Open Access | Times Cited: 7
Bacterial Resistance in Hospital-Acquired Infections Acquired in the Intensive Care Unit: A Systematic Review
Walter Martinez Loaiza, Anny Katheryne Rivera Ruiz, Cristian Camilo Ospina Patiño, et al.
Acta Medica (Hradec Kralove Czech Republic) (2023) Vol. 66, Iss. 1, pp. 1-10
Open Access | Times Cited: 3
Real-world in vitro activity of newer antibiotics against Enterobacterales and Pseudomonas aeruginosa , including carbapenem-non-susceptible and multidrug-resistant isolates: a multicenter analysis
Todd Riccobene, ChinEn Ai, Kalvin Yu, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 3
Antimicrobial Susceptibility of Klebsiella pneumoniae Isolated from Intensive and Non-intensive Care Units Patients: A One-year Retrospective Study in a Tertiary Healthcare Hospital, Saudi Arabia
Nouran M. Moustafa, Fatma Mahmoud, Noor Wael Bu Khamsin, et al.
Journal of Pure and Applied Microbiology (2023) Vol. 17, Iss. 4, pp. 2453-2466
Open Access | Times Cited: 3
Evaluation of in vitro activity of ceftolozane/tazobactam and comparators against recent clinical bacterial isolates, and genomics of Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli isolates that demonstrated resistance to ceftolozane/tazobactam: data from Kuwait and Oman
Wadha Alfouzan, Rita Dhar, Jalila Mohsin, et al.
JAC-Antimicrobial Resistance (2022) Vol. 4, Iss. 2
Open Access | Times Cited: 5
Satisfactory In Vitro Activity of Ceftolozane–Tazobactam against Carbapenem-Resistant Pseudomonas aeruginosa But Not against Klebsiella pneumoniae Isolates
Alicja Sękowska, Marta Grabowska, Tomasz Bogiel
Medicina (2023) Vol. 59, Iss. 3, pp. 518-518
Open Access | Times Cited: 2
Burden of severe infections due to carbapenem-resistant pathogens in intensive care unit
Maria Caterina Pace, Antonio Corrente, Maria Beatrice Passavanti, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 13, pp. 2874-2889
Open Access | Times Cited: 2
Modulation of Pseudomonas aeruginosa quorum sensing by ajoene through direct competition with small RNAs for binding at the proximal site of Hfq – A structure-based perspective
Ana Thereza Fiori-Duarte, Luciana Bitencourt de Souza Ferreira, Amanda Sanches Ascencio, et al.
Gene (2023) Vol. 877, pp. 147506-147506
Open Access | Times Cited: 2
Role of β-lactamases and efflux pumps in multidrug resistance inPseudomonas aeruginosaisolated from patients in the Intensive Care Unit in the northeast of Brazil
Marília S. Maia, Lavouisier F.B. Nogueira, Marco Clementino, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Nhiễm trùng do các trực khuẩn Gram âm thường gặp tại Trung tâm Hồi sức tích cực, Bệnh viện Bạch Mai năm 2023
Phạm Hồng Nhung, Nguyễn Tuấn Linh
Tạp chí Nghiên cứu Y học (2024) Vol. 178, Iss. 5, pp. 43-51
Open Access
Prevalence of rectal carbapenem resistant Enterobacterales carriage among patients attending healthcare facilities in Ibadan, Nigeria: a descriptive study
Olukemi Adekanmbi, Oluwafemi Popoola, Adeola Fowotade, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top